2004 Tour of Hope™ Team Members Announced
Team members include Kristen Adelman, Elkridge, Md.; Colleen Chapleau, North Liberty, Iowa; John Fee, Delran, N.J.; Andrea Glassberg, San Francisco, Calif.; Brandon Hayes-Lattin, Portland, Ore.; Brian Highhouse, Meriden, N.H.; Sheila McGuirk, Madison, Wis.; Darren Mullen, Wichita, Kan.; Jim Owens, Edina, Minn.; Kathy Parker, Athens, Ga.; Rod Quiros, Suffern, N.Y.; Erika Rosettie, Corning, N.Y.; Neil Shah, Woodland Hills, Calif.; Bernie Sher, Cocoa Beach, Fla.; Michael Siegel, Wilmette, Ill.; Joseph Steele, Englewood, Colo.; Elizabeth Sterling, Millmont, Penn.; Robert Stuart, Charleston, S.C.; Stephen Verbanic, Virginia Beach, Va.; and Ted Yang, Houston, Texas.
Cancer.gov Site Redesigned
The new site combines a warm, visually appealing design with an improved navigation function, enabling users to easily find the information they want most. The new home page presents information by cancer type, and the basic clinical trial search form is just one click away. Additionally, information about NCI research programs and funding has been centralized into one content area. NCI plans to continue refining its Web site to meet the needs of all members of the NCI community.
NCI at ASCO
Symptom Management Trials Get Case Reimbursement Increase
For the past several years, cancer treatment trials have been funded at $2,000 per case and symptom management trials funded at $1,000 per case. Reimbursement was increased to recognize the increased workload associated with symptom management trials, as well as to reinforce the importance of symptom management trials to the extramural community. Reducing the pain and suffering from cancer is a critical NCI goal and clinical trials are an essential means of determining effective regimens for cancer therapy and for alleviating symptoms of cancer or cancer treatment. More than 130 symptom management trials have been conducted since 1989.
The Cooperative Groups and several Cancer Centers are funded by the Division of Cancer Prevention as NCI Community Clinical Oncology Program (CCOP) Research Bases to design, develop, and conduct cancer prevention and control trials. For more information on the CCOP network, go to http://www3.cancer.gov/prevention/ccop/facts.html. For information on symptom management research go to http://www3.cancer.gov/prevention/coptrg/supportivecare/index.html.